|
|
|
Insider
Information: |
Andreotti Lamberto |
Relationship: |
|
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,011,868 |
|
Indirect Shares
|
241,273 |
|
|
Direct
Value |
$41,048,627 |
|
|
Indirect Value
|
$9,913,908 |
|
|
Total
Shares |
1,253,141 |
|
|
Total
Value |
$50,962,535 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
14.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
Director |
2017-04-07 |
935,571 |
2017-04-07 |
241,273 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-12-23 |
19,609 |
2009-02-17 |
0 |
Premium* |
|
DuPont de Nemours Inc |
DD |
Director |
2017-08-31 |
0 |
2012-08-02 |
0 |
Premium* |
|
Dowdupont Inc. |
DWDP |
Director |
2019-05-21 |
22,231 |
|
0 |
Premium* |
|
Corteva, Inc. |
CTVA |
|
2024-04-26 |
34,457 |
2019-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
218 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
116,000 |
312,089 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
|
2005-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
232,259 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2016-02-04 |
4 |
D |
$59.70 |
$7,648,704 |
D/D |
(128,119) |
416,054 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2015-03-02 |
4 |
D |
$62.30 |
$8,044,488 |
D/D |
(129,125) |
514,839 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-09-05 |
4 |
OE |
$23.14 |
$3,123,900 |
D/D |
135,000 |
514,491 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2016-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
148,180 |
445,820 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2013-03-07 |
4 |
D |
$37.53 |
$7,431,503 |
D/D |
(198,015) |
568,468 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2016-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
204,447 |
574,101 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
231,280 |
643,964 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2016-05-02 |
4 |
S |
$71.87 |
$16,870,792 |
D/D |
(234,720) |
436,794 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2016-05-02 |
4 |
OE |
$24.74 |
$6,112,787 |
D/D |
234,720 |
671,514 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2014-03-03 |
4 |
D |
$0.00 |
$3,294,021 |
D/D |
(264,757) |
709,143 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2016-11-01 |
4 |
OE |
$22.14 |
$6,772,825 |
D/D |
305,909 |
998,777 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2015-08-03 |
4 |
OE |
$22.73 |
$7,561,950 |
D/D |
315,000 |
885,074 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2015-08-03 |
4 |
S |
$64.75 |
$20,589,328 |
D/D |
(315,000) |
570,074 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2013-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
330,160 |
739,611 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2016-10-11 |
4 |
OE |
$17.51 |
$6,456,042 |
D/D |
368,706 |
692,868 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2014-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
423,533 |
912,318 |
0 |
- |
|
218 Records found
|
|
Page 9 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|